MedPath
NMPA Approval

Pefloxacin Mesylate for Injection

国药准字H20059982

August 16, 2024

Drug Information

注射用甲磺酸培氟沙星

注射剂

0.4g(按C17H20FN3O3计)

化学药品

August 16, 2024

Company Information

Applicant Company

海南省海口市国家高新技术产业开发区药谷工业园区药谷二路2号1号楼3楼305室

Manufacturing Company

海口保税区六号厂房西C区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用甲磺酸培氟沙星 - NMPA 批准文号 | MedPath